Clinical Trial

Validation of STARZ Score for Early Neonatal AKI

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Neonatal acute kidney injury (AKI) is a common complication in the NICU, associated with high morbidity and mortality. Prematurity, low birthweight, sepsis, asphyxia, congenital heart disease, and nephrotoxic drugs are major risk factors. Early diagnosis is challenging as serum creatinine lacks sensitivity. The STARZ score, a composite clinical-laboratory tool, has shown high accuracy for predicting early neonatal AKI. This study aims to validate the STARZ score in neonates admitted to Assiut University Children's Hospital for early identification of AKI and improved clinical outcomes."
Trial Details
NCT Number NCT07202858
Lead Sponsor Assiut University
Conditions Acute Kidney Injury, Kidney Diseases, Newborn
Enrollment 140 participants
Start Date 2025-10-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2025-10-02